Literature DB >> 16203964

The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.

Samuel Bouyain1, Patti A Longo, Shiqing Li, Kathryn M Ferguson, Daniel J Leahy.   

Abstract

The human ErbB family of receptor tyrosine kinases comprises the epidermal growth factor receptor (EGFR/ErbB1/HER1), ErbB2 (HER2/Neu), ErbB3 (HER3), and ErbB4 (HER4). ErbBs play fundamental roles in cell growth and differentiation events in embryonic and adult tissues, and inappropriate ErbB activity has been implicated in several human cancers. We report here the 2.4 A crystal structure of the extracellular region of human ErbB4 in the absence of ligand and show that it adopts a tethered conformation similar to inactive forms of ErbB1 and ErbB3. This structure completes the gallery of unliganded ErbB receptors and demonstrates that all human ligand-binding ErbBs adopt the autoinhibited conformation. We also show that the binding of neuregulin-1beta to ErbB4 and ErbB3 and the binding of betacellulin to both ErbB4 and ErbB1 does not decrease at low pH, unlike the binding of epidermal growth factor and transforming growth factor-alpha to ErbB1. These results indicate an important role for ligand in determining pH-dependent binding and may explain different responses observed when the same ErbB receptor is stimulated by different ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203964      PMCID: PMC1257738          DOI: 10.1073/pnas.0507591102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

Review 3.  The anatomy and taxonomy of protein structure.

Authors:  J S Richardson
Journal:  Adv Protein Chem       Date:  1981

4.  Extracellular domains drive homo- but not hetero-dimerization of erbB receptors.

Authors:  K M Ferguson; P J Darling; M J Mohan; T L Macatee; M A Lemmon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  A mammalian expression vector for expression and purification of secreted proteins for structural studies.

Authors:  D J Leahy; C E Dann; P Longo; B Perman; K X Ramyar
Journal:  Protein Expr Purif       Date:  2000-12       Impact factor: 1.650

6.  Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.

Authors:  Hyun-Soo Cho; Karen Mason; Kasra X Ramyar; Ann Marie Stanley; Sandra B Gabelli; Dan W Denney; Daniel J Leahy
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

7.  Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor.

Authors:  J M Culouscou; G D Plowman; G W Carlton; J M Green; M Shoyab
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

8.  ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.

Authors:  E Tzahar; G Levkowitz; D Karunagaran; L Yi; E Peles; S Lavi; D Chang; N Liu; A Yayon; D Wen
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

9.  ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.

Authors:  Mitchell B Berger; Jeannine M Mendrola; Mark A Lemmon
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

Review 10.  An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.

Authors:  Antony W Burgess; Hyun-Soo Cho; Charles Eigenbrot; Kathryn M Ferguson; Thomas P J Garrett; Daniel J Leahy; Mark A Lemmon; Mark X Sliwkowski; Colin W Ward; Shigeyuki Yokoyama
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

View more
  79 in total

1.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

Review 2.  The ERBB network: at last, cancer therapy meets systems biology.

Authors:  Yosef Yarden; Gur Pines
Journal:  Nat Rev Cancer       Date:  2012-07-12       Impact factor: 60.716

3.  Structural basis for negative cooperativity in growth factor binding to an EGF receptor.

Authors:  Diego Alvarado; Daryl E Klein; Mark A Lemmon
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

4.  Old dog, new tricks: extracellular domain arginine methylation regulates EGFR function.

Authors:  David M Epstein; Elizabeth Buck
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 5.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

6.  Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions.

Authors:  Christian Jost; Jakob C Stüber; Annemarie Honegger; Yufan Wu; Alexander Batyuk; Andreas Plückthun
Journal:  Protein Sci       Date:  2017-07-05       Impact factor: 6.725

7.  Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martínez-Salazar
Journal:  J Mol Model       Date:  2012-10-23       Impact factor: 1.810

8.  Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.

Authors:  Motoko Takahashi; Yoshihiro Hasegawa; Yoshitaka Ikeda; Yoshinao Wada; Michiko Tajiri; Shigeru Ariki; Rina Takamiya; Chiaki Nishitani; Motoko Araki; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

9.  Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells.

Authors:  Mikkel Staberg; Christian Riemer; Ruodan Xu; Oksana Dmytriyeva; Elisabeth Bock; Vladimir Berezin
Journal:  Cell Oncol (Dordr)       Date:  2013-04-12       Impact factor: 6.730

Review 10.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.